I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

South Africa has slashed HIV deaths by over 20% in two years thanks to world-leading ART access — but diabetes and heart ...

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

CVS Health ( CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens.

A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...

As per SNS Insider Research, North America Leads the Market with 42% Market Share, While Asia Pacific Emerges as the Fastest Growing Region with Strong Adoption of Connected Diabetes ...

SAN DIEGO - Tandem Diabetes Care, Inc. (NASDAQ:TNDM) announced Monday that the U.S. Food and Drug Administration has cleared the Android version of its Tandem Mobi mobile app, expanding accessibility ...

Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...